메뉴 건너뛰기




Volumn 35, Issue 7, 2013, Pages

Comparison of hypersensitivity reactions to PEG-asparaginase in children after intravenous and intramuscular administration

Author keywords

acute lymphoblastic leukemia; asparaginase; hypersensitivity reactions; pediatrics

Indexed keywords

ASPARAGINASE MACROGOL;

EID: 84885182239     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31828e5471     Document Type: Article
Times cited : (22)

References (30)
  • 1
    • 27244447048 scopus 로고    scopus 로고
    • Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia
    • Pession A, Valsecchi MG, Masera G, et al. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia. J Clin Oncol. 2005;23:7161-7167.
    • (2005) J Clin Oncol , vol.23 , pp. 7161-7167
    • Pession, A.1    Valsecchi, M.G.2    Masera, G.3
  • 2
    • 0032973925 scopus 로고    scopus 로고
    • Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: A Pediatric Oncology Group study
    • Amylon MD, Shuster J, Pullen J, et al. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia. 1999;13:335-342.
    • (1999) Leukemia , vol.13 , pp. 335-342
    • Amylon, M.D.1    Shuster, J.2    Pullen, J.3
  • 3
    • 0000973839 scopus 로고
    • Antibodies to asparaginase alter pharmacokinetics and decrease enzyme activity in patients on asparaginase theapy
    • Kurtzberg J, Asselin B, Poplack D, et al. Antibodies to asparaginase alter pharmacokinetics and decrease enzyme activity in patients on asparaginase theapy. Proc Annu Meet Am Assoc Cancer Res. 1993;34:A1807.
    • (1993) Proc Annu Meet Am Assoc Cancer Res , vol.34
    • Kurtzberg, J.1    Asselin, B.2    Poplack, D.3
  • 4
    • 0021032126 scopus 로고
    • Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia
    • Sallan SE, Hitchcock-Bryan S, Gelber R, et al. Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res. 1983;43:5601-5607.
    • (1983) Cancer Res , vol.43 , pp. 5601-5607
    • Sallan, S.E.1    Hitchcock-Bryan, S.2    Gelber, R.3
  • 5
    • 0027197614 scopus 로고
    • Comparative pharmacokinetic studies of three asparaginase preparations
    • Asselin BL, Whitin JC, Coppola DJ, et al. Comparative pharmacokinetic studies of three asparaginase preparations. J Clin Oncol. 1993;11:1780-1786.
    • (1993) J Clin Oncol , vol.11 , pp. 1780-1786
    • Asselin, B.L.1    Whitin, J.C.2    Coppola, D.J.3
  • 6
    • 2442496750 scopus 로고    scopus 로고
    • Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961
    • Panosyan EH, Seibel NL, Martin-Aragon S, et al. Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961. J Pediatr Hematol Oncol. 2004;26: 217-226.
    • (2004) J Pediatr Hematol Oncol , vol.26 , pp. 217-226
    • Panosyan, E.H.1    Seibel, N.L.2    Martin-Aragon, S.3
  • 7
    • 84863116322 scopus 로고    scopus 로고
    • Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia
    • Kawedia JD, Liu C, Pei D, et al. Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia. Blood. 2012;119:1658-1664.
    • (2012) Blood , vol.119 , pp. 1658-1664
    • Kawedia, J.D.1    Liu, C.2    Pei, D.3
  • 8
    • 0034117076 scopus 로고    scopus 로고
    • Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia
    • Woo MH, Hak LJ, Storm MC, et al. Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol. 2000;18:1525-1532.
    • (2000) J Clin Oncol , vol.18 , pp. 1525-1532
    • Woo, M.H.1    Hak, L.J.2    Storm, M.C.3
  • 9
    • 0037085747 scopus 로고    scopus 로고
    • A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: A Children's Cancer Group study
    • Avramis VI, Sencer S, Periclou AP, et al. A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood. 2002;99:1986-1994.
    • (2002) Blood , vol.99 , pp. 1986-1994
    • Avramis, V.I.1    Sencer, S.2    Periclou, A.P.3
  • 10
    • 0035018209 scopus 로고    scopus 로고
    • Drug monitoring of low-dose PEG-asparaginase (Oncaspar) in children with relapsed acute lymphoblastic leukaemia
    • Vieira Pinheiro JP, Muller HJ, Schwabe D, et al. Drug monitoring of low-dose PEG-asparaginase (Oncaspar) in children with relapsed acute lymphoblastic leukaemia. Br J Haematol. 2001;113:115-119.
    • (2001) Br J Haematol , vol.113 , pp. 115-119
    • Vieira Pinheiro, J.P.1    Muller, H.J.2    Schwabe, D.3
  • 11
    • 0018617937 scopus 로고
    • Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia
    • Nesbit M, Chard R, Evans A, et al. Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia. Am J Pediatr Hematol Oncol. 1979; 1:9-13.
    • (1979) Am J Pediatr Hematol Oncol , vol.1 , pp. 9-13
    • Nesbit, M.1    Chard, R.2    Evans, A.3
  • 12
    • 0036163591 scopus 로고    scopus 로고
    • PEG-asparaginase (Oncaspar) 2500 U/m(2) BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols
    • Muller HJ, Beier R, da Palma JC, et al. PEG-asparaginase (Oncaspar) 2500 U/m(2) BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols. Cancer Chemother Pharmacol. 2002;49:149-154.
    • (2002) Cancer Chemother Pharmacol , vol.49 , pp. 149-154
    • Muller, H.J.1    Beier, R.2    Da Palma, J.C.3
  • 13
    • 0033836246 scopus 로고    scopus 로고
    • Pegylated asparaginase (Oncaspar) in children with ALL: Drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols
    • Muller HJ, Loning L, Horn A, et al. Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols. Br J Haematol. 2000;110:379-384.
    • (2000) Br J Haematol , vol.110 , pp. 379-384
    • Muller, H.J.1    Loning, L.2    Horn, A.3
  • 14
    • 77949895397 scopus 로고    scopus 로고
    • Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia
    • Silverman LB, Supko JG, Stevenson KE, et al. Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia. Blood. 2010;115:1351-1353.
    • (2010) Blood , vol.115 , pp. 1351-1353
    • Silverman, L.B.1    Supko, J.G.2    Stevenson, K.E.3
  • 15
    • 0022443776 scopus 로고
    • Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia
    • Clavell LA, Gelber RD, Cohen HJ, et al. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med. 1986;315: 657-663.
    • (1986) N Engl J Med , vol.315 , pp. 657-663
    • Clavell, L.A.1    Gelber, R.D.2    Cohen, H.J.3
  • 16
    • 0028204905 scopus 로고
    • Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01
    • Schorin MA, Blattner S, Gelber RD, et al. Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01. J Clin Oncol. 1994;12:740-747.
    • (1994) J Clin Oncol , vol.12 , pp. 740-747
    • Schorin, M.A.1    Blattner, S.2    Gelber, R.D.3
  • 17
    • 0034284267 scopus 로고    scopus 로고
    • Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: A Pediatric Oncology Group Study
    • Abshire TC, Pollock BH, Billett AL, et al. Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Blood. 2000;96:1709-1715.
    • (2000) Blood , vol.96 , pp. 1709-1715
    • Abshire, T.C.1    Pollock, B.H.2    Billett, A.L.3
  • 18
    • 0017360242 scopus 로고
    • L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia
    • Ortega JA, Nesbit ME Jr., Donaldson MH, et al. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia. Cancer Res. 1977;37:535-540.
    • (1977) Cancer Res , vol.37 , pp. 535-540
    • Ortega, J.A.1    Nesbit Jr., M.E.2    Donaldson, M.H.3
  • 19
    • 0020080755 scopus 로고
    • Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma
    • Evans WE, Tsiatis A, Rivera G, et al. Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma. Cancer. 1982;49:1378-1383.
    • (1982) Cancer , vol.49 , pp. 1378-1383
    • Evans, W.E.1    Tsiatis, A.2    Rivera, G.3
  • 20
    • 0022982465 scopus 로고
    • Antibody response to Escherichia coli L-asparaginase. Prognostic significance and clinical utility of antibody measurement
    • Cheung NK, Chau IY, Coccia PF. Antibody response to Escherichia coli L-asparaginase. Prognostic significance and clinical utility of antibody measurement. Am J Pediatr Hematol Oncol. 1986;8:99-104.
    • (1986) Am J Pediatr Hematol Oncol , vol.8 , pp. 99-104
    • Cheung, N.K.1    Chau, I.Y.2    Coccia, P.F.3
  • 21
    • 0017177135 scopus 로고
    • Comparison of anaphylactic reactions to asparaginase derived from Escherichia coli and from Erwinia cultures
    • Dellinger CT, Miale TD. Comparison of anaphylactic reactions to asparaginase derived from Escherichia coli and from Erwinia cultures. Cancer. 1976;38:1843-1846.
    • (1976) Cancer , vol.38 , pp. 1843-1846
    • Dellinger, C.T.1    Miale, T.D.2
  • 22
    • 33947600985 scopus 로고    scopus 로고
    • Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia
    • Douer D, Yampolsky H, Cohen LJ, et al. Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia. Blood. 2007;109: 2744-2750.
    • (2007) Blood , vol.109 , pp. 2744-2750
    • Douer, D.1    Yampolsky, H.2    Cohen, L.J.3
  • 23
    • 32544457262 scopus 로고    scopus 로고
    • A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia
    • Rizzari C, Citterio M, Zucchetti M, et al. A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia. Haematologica. 2006;91:24-31.
    • (2006) Haematologica , vol.91 , pp. 24-31
    • Rizzari, C.1    Citterio, M.2    Zucchetti, M.3
  • 24
    • 84885181101 scopus 로고    scopus 로고
    • Randomized Comparison of IV PEG and im e coli asparaginase in children and adolescents with acute lymphoblastic leukemia: Results of the DFCI ALL Consortium Protocol 05-01
    • Silverman LB, Stevenson K, Vrooman LM, et al. Randomized Comparison of IV PEG and IM E. coli asparaginase in children and adolescents with acute lymphoblastic leukemia: results of the DFCI ALL Consortium Protocol 05-01. ASH Annual Meeting Abstracts. 2011;118:874.
    • (2011) ASH Annual Meeting Abstracts , vol.118 , pp. 874
    • Silverman, L.B.1    Stevenson, K.2    Vrooman, L.M.3
  • 25
    • 0026684162 scopus 로고
    • Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase
    • Billett AL, Carls A, Gelber RD, et al. Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase. Cancer. 1992;70:201-206.
    • (1992) Cancer , vol.70 , pp. 201-206
    • Billett, A.L.1    Carls, A.2    Gelber, R.D.3
  • 26
    • 0031681258 scopus 로고    scopus 로고
    • Anti-asparaginase antibodies following e coli asparaginase therapy in pediatric acute lymphoblastic leukemia
    • Woo MH, Hak LJ, Storm MC, et al. Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia. Leukemia. 1998;12:1527-1533.
    • (1998) Leukemia , vol.12 , pp. 1527-1533
    • Woo, M.H.1    Hak, L.J.2    Storm, M.C.3
  • 27
    • 0017253880 scopus 로고
    • Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia
    • Killander D, Dohlwitz A, Engstedt L, et al. Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia. Cancer. 1976;37:220-228.
    • (1976) Cancer , vol.37 , pp. 220-228
    • Killander, D.1    Dohlwitz, A.2    Engstedt, L.3
  • 28
    • 0031893235 scopus 로고    scopus 로고
    • Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia
    • Larson RA, Fretzin MH, Dodge RK, et al. Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia. Leukemia. 1998;12:660-665.
    • (1998) Leukemia , vol.12 , pp. 660-665
    • Larson, R.A.1    Fretzin, M.H.2    Dodge, R.K.3
  • 29
    • 34548387897 scopus 로고    scopus 로고
    • Allergic reactions to E. Coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: A Children's Oncology Group Study
    • Wacker P, Land VJ, Camitta BM, et al. Allergic reactions to E. coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: a Children's Oncology Group Study. J Pediatr Hematol Oncol. 2007;29: 627-632.
    • (2007) J Pediatr Hematol Oncol , vol.29 , pp. 627-632
    • Wacker, P.1    Land, V.J.2    Camitta, B.M.3
  • 30
    • 0035283163 scopus 로고    scopus 로고
    • Improved outcome for children with acute lymphoblastic leukemia: Results of Dana-Farber Consortium Protocol 91-01
    • Silverman LB, Gelber RD, Dalton VK, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood. 2001;97:1211-1218.
    • (2001) Blood , vol.97 , pp. 1211-1218
    • Silverman, L.B.1    Gelber, R.D.2    Dalton, V.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.